Geoff Beecher

For nearly four decades, Geoff Beecher has helped innovative medical technologies move from invention to clinical practice — working alongside physician innovators, engineers, founders, and executive teams across minimally invasive surgery, women's health, breast oncology, musculoskeletal intervention, vascular access, molecular diagnostics, and AI-enabled decision support.

His work is guided by a single question: what must be true for a technology to achieve clinical, economic, and operational adoption. That question has shaped commercialization strategy, physician adoption, reimbursement planning, and market development for venture-backed companies through strategic acquisition — and continues to guide his work today at Phraxis, ASTERintel, and Echelon Development Group.

Four decades, one throughline

CAREER JOURNEY

A career built by repeatedly entering uncertain markets — helping physicians understand new technologies, and helping innovative companies grow toward strategic acquisition.

How Geoff thinks

Clinical success is necessary—but never sufficient.

Regulatory approval is only the beginning. Successful commercialization requires alignment between clinical evidence, reimbursement, physician workflow, operational execution, and sustainable economics.

Reimbursement strategy should begin alongside regulatory strategy.

FDA and CMS answer different questions. Companies that develop these strategies in parallel reduce commercialization risk.

Commercialization is an operational discipline.

The most successful technologies integrate naturally into physician workflow, hospital operations, and patient care—not simply clinical practice.

Controlled launches create better companies.

Commercialization should validate assumptions before accelerating growth. Learning early prevents expensive mistakes later.

COMMERCIALIZATION PHILOSOPHY

Physician confidence drives adoption.

Innovative technologies become standard of care only after physicians gain confidence through evidence, education, workflow integration, and experience.

EndoForce™

Built a commercial plan and Post-Approval Study execution framework and supported the first post-FDA commercial cases and first PAS case in the world.

SELECTED COMMERCIALIZATION PROGRAMS

A selection of the medical technologies Geoff has helped commercialize, spanning eight therapeutic areas and nearly four decades.

Technologies brought to market

Phraxis · Vascular Access

"Commercialization begins before product launch."

Ellipsys®

Identified that physician adoption alone would not determine success. Built maturation protocols, dialysis education, and downstream cannulation support around the patient pathway.

Avenu Medical · Vascular Access / Dialysis

"Successful procedures require successful patient pathways."

BioZorb®

Focal Therapeutics · Breast Oncology

Worked alongside breast surgeons and radiation oncologists to support multidisciplinary adoption and advanced applications.

"Technologies that improve the continuum of care can create greater long-term value."

NovaSure®

Novacept · Women's Health

Helped introduce a minimally invasive treatment option in women's health.

"Innovation succeeds when it gives physicians—and patients—a better choice."

Contura®

SenoRx · Breast Brachytherapy

Commercialized a multi-lumen breast brachytherapy device, converting multidisciplinary breast-care and cancer specialists.

Proxima Therapeutics · Breast Oncology

Commercialized an Accelerated Partial Breast Irradiation therapy for early-stage breast cancer.

Harmonic Scalpel® & Mammotome®

Ethicon Endo-Surgery, Johnson & Johnson · Minimally Invasive Surgery & Breast Care

Commercialized across a multi-year tenure progressing from Territory Representative to Market Development Manager.

MammoSite®

CURRENT WORK

Commercialization leadership for EndoForce™ vascular access technology.

Where Geoff works today

PHRAXIS, INC.

CHIEF COMMERCIAL OFFICER

Applying AI-enabled decision intelligence to MedTech commercialization and investment strategy.

ASTERIntel

CO-FOUNDER

CO-FOUNDER & PRINCIPAL

ECHELON DEVELOPMENT GROUP

Strategic commercialization advisory for emerging medical technology companies.

RESOURCES

The complete record

Executive Resume

Commercialization Portfolio

Career Evidence Appendix

Executive Biography

CONTACT

Continue the conversation

Geoff welcomes conversations regarding MedTech commercialization, executive leadership, advisory opportunities, board service, speaking engagements, and strategic collaboration.

gbeecher56@gmail.com

Connect on LinkedIn